Patient and graft survival in pancreas transplant recipients: the EFISPAN study

Introduction and objectives: Graft outcomes in pancreas transplantation have improved in recent decades, but data are mainly derived from registries or prospective single-centre studies. This large epidemiological study was undertaken to investigate the impact of clini cal and demographic factors on...

Descripción completa

Detalles Bibliográficos
Autores: Ventura-Aguiar, Pedro, Cabello, Mercedes, Beneyto, Isabel, Navarro Cabello, Dolores, Tabernero, Guadalupe, Alonso, Ángel, Ruiz San Millán, Juan Carlos|||0000-0002-7904-8730, Llorente, Santiago
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad de Cantabria (UC)
Repositorio:UCrea Repositorio Abierto de la Universidad de Cantabria
Idioma:inglés
OAI Identifier:oai:repositorio.unican.es:10902/29636
Acceso en línea:https://hdl.handle.net/10902/29636
Access Level:acceso abierto
Palabra clave:Cardiovascular disease
Diabetes
Graft survival
Kidney disease
Kidney transplant
Pancreas transplant
Descripción
Sumario:Introduction and objectives: Graft outcomes in pancreas transplantation have improved in recent decades, but data are mainly derived from registries or prospective single-centre studies. This large epidemiological study was undertaken to investigate the impact of clini cal and demographic factors on graft and patient survival in pancreas transplant recipients in Spain, and to provide robust, country-wide, practice-based data to complement registry findings. Patients and methods: We conducted a retrospective, longitudinal, epidemiological study to assess risk factors impacting patient and graft survival in pancreas transplant recipients in eight centres in Spain. All patients transplanted between 1 January 2008 and 31 December 2012 were included; data were collected until 31 December 2015. The Kaplan?Meier method was used for all time-to-event analyses, including patient survival, graft survival, acute rejection, and BPAR. For graft survival analysis, in cases of death with functioning graft, patients were censored without any event on the date of death. For acute rejection and BPAR, patients were censored without any event on the date of death or graft loss. Univariable and multivariable analyses (Cox proportional hazards model) were conducted to assess the association between baseline clinical and demographic characteristics and patient/graft survival.